A 3 month open-label study of atomoxetine in children with attention-deficit/hyperactivity disorder; symptomatic and functional outcomes
Latest Information Update: 03 Aug 2006
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 03 Aug 2006 Status change
- 13 Nov 2005 New trial record.